STRATEGIC MARKETING ALLIANCE AGREEMENTMarketing Alliance Agreement • June 28th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • New Jersey
This Strategic Marketing Alliance Agreement (this “Agreement”) is made as of this day of March, 2016 (the “Effective Date”), by and between Napo Pharmaceuticals, Inc., a Delaware corporation, and its successors and assigns (collectively, “Napo”) and SmartPharma, LLC, a New Jersey limited liability company (“SP”) (each of Napo and SP may be referred to as a “Party” and, collectively, the “Parties”).
Master Manufacturing Services Agreement May 21, 2013Product Agreement • June 28th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound, the parties agree as follows:
AMENDMENT, WAIVER & CONSENTJaguar Animal Health, Inc. • June 28th, 2017 • Pharmaceutical preparations
This Amendment, Waiver & Consent (this “Consent”) is entered into effective as of June 27, 2017 by and among Jaguar Animal Health, Inc., a Delaware corporation (“Jaguar”), Napo Pharmaceuticals, Inc., a Delaware Corporation (“Napo”), and Nantucket Investments Limited, a company organized under the laws of Guernsey (“Nantucket”), pursuant to and in connection with that certain Investor Rights Agreement by and between Jaguar and Nantucket, dated March 31, 2017 (the “IRA”), that certain Settlement and Discounted Payoff Agreement by and among Napo, Nantucket and the lenders party thereto, dated March 31, 2017 (the “Settlement Agreement”), and that certain Agreement and Plan of Merger by and among Jaguar, Napo Acquisition Corporation, a Delaware corporation, Napo and Gregory Stock as the Napo Representative, dated March 31, 2017 (the “Merger Agreement” and, collectively with the IRA and the Settlement Agreement, the “Transaction Agreements”). All terms not defined herein shall have the meani
MARKETING AND DISTRIBUTION AGREEMENTMarketing and Distribution Agreement • June 28th, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Texas
This MARKETING AND DISTRIBUTION AGREEMENT (this “Agreement”) is made as of April 14, 2016 (the “Effective Date”), by and among Napo Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business at 301 Main Street # 30G, San Francisco, California 94105 (“Napo”), and BexR Logistix, LLC, a Texas limited liability company (“BexR”) with its principal place of business at 10999 Interstate Highway 10 West, Suite 1000, San Antonio, TX 78230-1355. (Napo and BexR are also sometimes referred to herein as the “parties” or individually as a “party”).
